Perrigo Co. Selling $2.3 Billion In Debt To Finance Elan PurchaseThe Allegan generic pharmaceutical and store-brand health products maker Perrigo Co. Ltd., which moved its corporate registration to Ireland earlier this year, said it would offer debt totaling $2.3 billion with maturities in 2016, 2018, 2023 and 2043.
Perrigo Reports Record Quarterly Revenue, ProfitThe generic drug and health and beauty product manufacturer Perrigo Co. Tuesday reported record revenue and profit for the second fiscal quarter ended Dec. 31.
Perrigo Reports Record Earnings, Raises EPS Guidance
GR Health Products Company Buys In Europe